290 related articles for article (PubMed ID: 30583079)
1. Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
Takeda S; Shigeyasu K; Okugawa Y; Yoshida K; Mori Y; Yano S; Noma K; Umeda Y; Kondo Y; Kishimoto H; Teraishi F; Nagasaka T; Tazawa H; Kagawa S; Fujiwara T; Goel A
Cancer Lett; 2019 Mar; 444():127-135. PubMed ID: 30583079
[TBL] [Abstract][Full Text] [Related]
2. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.
Shigeyasu K; Okugawa Y; Toden S; Miyoshi J; Toiyama Y; Nagasaka T; Takahashi N; Kusunoki M; Takayama T; Yamada Y; Fujiwara T; Chen L; Goel A
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925690
[TBL] [Abstract][Full Text] [Related]
3. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
[TBL] [Abstract][Full Text] [Related]
4. ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer.
Nakamura K; Shigeyasu K; Okamoto K; Matsuoka H; Masuyama H
Gynecol Oncol; 2022 Aug; 166(2):326-333. PubMed ID: 35697535
[TBL] [Abstract][Full Text] [Related]
5. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
[TBL] [Abstract][Full Text] [Related]
6. RNA editing of AZIN1 coding sites is catalyzed by ADAR1 p150 after splicing.
Xing Y; Nakahama T; Wu Y; Inoue M; Kim JI; Todo H; Shibuya T; Kato Y; Kawahara Y
J Biol Chem; 2023 Jul; 299(7):104840. PubMed ID: 37209819
[TBL] [Abstract][Full Text] [Related]
7. A novel mechanism for A-to-I RNA-edited AZIN1 in promoting tumor angiogenesis in colorectal cancer.
Wei Y; Zhang H; Feng Q; Wang S; Shao Y; Wu J; Jin G; Lin W; Peng X; Xu X
Cell Death Dis; 2022 Apr; 13(4):294. PubMed ID: 35365616
[TBL] [Abstract][Full Text] [Related]
8. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.
Chen L; Li Y; Lin CH; Chan TH; Chow RK; Song Y; Liu M; Yuan YF; Fu L; Kong KL; Qi L; Li Y; Zhang N; Tong AH; Kwong DL; Man K; Lo CM; Lok S; Tenen DG; Guan XY
Nat Med; 2013 Feb; 19(2):209-16. PubMed ID: 23291631
[TBL] [Abstract][Full Text] [Related]
9. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
[No Abstract] [Full Text] [Related]
10. An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks.
Ramírez-Moya J; Miliotis C; Baker AR; Gregory RI; Slack FJ; Santisteban P
Mol Cancer; 2021 Sep; 20(1):115. PubMed ID: 34496885
[TBL] [Abstract][Full Text] [Related]
11. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
[No Abstract] [Full Text] [Related]
12. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
Ramírez-Moya J; Baker AR; Slack FJ; Santisteban P
Oncogene; 2020 Apr; 39(18):3738-3753. PubMed ID: 32157211
[TBL] [Abstract][Full Text] [Related]
13. ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer.
Hata N; Shigeyasu K; Umeda Y; Yano S; Takeda S; Yoshida K; Fuji T; Yoshida R; Yasui K; Umeda H; Takahashi T; Kondo Y; Kishimoto H; Mori Y; Teraishi F; Yamamoto H; Michiue H; Nakamura K; Tazawa H; Fujiwara T
Sci Rep; 2023 Feb; 13(1):2078. PubMed ID: 36747029
[TBL] [Abstract][Full Text] [Related]
14. RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer.
Komatsu Y; Shigeyasu K; Yano S; Takeda S; Takahashi K; Hata N; Umeda H; Yoshida K; Mori Y; Yasui K; Yoshida R; Kondo Y; Kishimoto H; Teraishi F; Umeda Y; Kagawa S; Michiue H; Tazawa H; Goel A; Fujiwara T
Sci Rep; 2022 Aug; 12(1):13540. PubMed ID: 35941214
[TBL] [Abstract][Full Text] [Related]
15. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer.
Aizawa T; Karasawa H; Funayama R; Shirota M; Suzuki T; Maeda S; Suzuki H; Yamamura A; Naitoh T; Nakayama K; Unno M
Cancer Med; 2019 Oct; 8(14):6370-6382. PubMed ID: 31468733
[TBL] [Abstract][Full Text] [Related]
17. RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis.
Takahashi K; Shigeyasu K; Kondo Y; Gotoh K; Yano S; Umeda Y; Inokuchi T; Xu C; Yoshida K; Umeda H; Takahashi T; Takeda S; Yoshida R; Teraishi F; Kishimoto H; Mori Y; Noma K; Okugawa Y; Hiraoka S; Michiue H; Tazawa H; Matsushita O; Goel A; Fujiwara T
J Crohns Colitis; 2023 May; 17(5):754-766. PubMed ID: 36528792
[TBL] [Abstract][Full Text] [Related]
18. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
[TBL] [Abstract][Full Text] [Related]
19. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
[TBL] [Abstract][Full Text] [Related]
20. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
Nakano M; Fukami T; Gotoh S; Nakajima M
J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
